Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (461-470 of 512) with videos related to

Pageof 52
Sort By:
Journal of Hepatology|March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesMaja Thiele, Ida Falk Villesen, Lili Niu, et al.
JHEP Reports : Innovation in Hepatology|November 25, 2024
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter studyValeria Perez-Campuzano, Pierre-Emmanuel Rautou, Thomas Marjot, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2024
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosisMarcus M Mücke, María Hernández-Tejero, Wenyi Gu, et al.
Hepatology (Baltimore, Md.)|August 26, 2021
Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failureTao Lin, Shanshan Wang, Stefan Munker, et al.
Hepatology (Baltimore, Md.)|December 7, 2018
Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in CirrhosisJoan Clària, Richard Moreau, François Fenaille, et al.
Hepatology (Baltimore, Md.)|November 3, 2025
Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failureTao Lin, Shanshan Wang, Stefan Munker, et al.
American Journal of Physiology. Cell Physiology|June 5, 2023
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failureRobert Schierwagen, Wenyi Gu, Angela Brieger, et al.
Cell|November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associationsSuguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.
Gastroenterology|January 24, 2018
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With CirrhosisMacarena Simón-Talero, Davide Roccarina, Javier Martínez, et al.
Hepatology (Baltimore, Md.)|April 17, 2015
Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosisThierry Gustot, Javier Fernandez, Elisabet Garcia, et al.
Pageof 52

Showing results (461-470 of 512) with videos related to

Sort By:
Pageof 52
Journal of Hepatology|March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesMaja Thiele, Ida Falk Villesen, Lili Niu, et al.
JHEP Reports : Innovation in Hepatology|November 25, 2024
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter studyValeria Perez-Campuzano, Pierre-Emmanuel Rautou, Thomas Marjot, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2024
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosisMarcus M Mücke, María Hernández-Tejero, Wenyi Gu, et al.
Hepatology (Baltimore, Md.)|August 26, 2021
Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failureTao Lin, Shanshan Wang, Stefan Munker, et al.
Hepatology (Baltimore, Md.)|December 7, 2018
Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in CirrhosisJoan Clària, Richard Moreau, François Fenaille, et al.
Hepatology (Baltimore, Md.)|November 3, 2025
Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failureTao Lin, Shanshan Wang, Stefan Munker, et al.
American Journal of Physiology. Cell Physiology|June 5, 2023
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failureRobert Schierwagen, Wenyi Gu, Angela Brieger, et al.
Cell|November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associationsSuguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.
Gastroenterology|January 24, 2018
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With CirrhosisMacarena Simón-Talero, Davide Roccarina, Javier Martínez, et al.
Hepatology (Baltimore, Md.)|April 17, 2015
Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosisThierry Gustot, Javier Fernandez, Elisabet Garcia, et al.
Pageof 52